Marrow Therapeutics Series B: $173M
Marrow Therapeutics raised $173 million in a series b round led by Scion Life Sciences and Venbio Partners and OrbiMed, announced Nov. 17.
Facts
- Company
- Marrow Therapeutics
- Amount
- $173 million
- Currency
- USD
- Stage
- Series B
- Announced
- Nov 17, 2026
Investors
Use of funds
Building manufacturing capacity.
Sources
- 1.Sickle Cell Drug: Marrow Raises $173 Million Without Releasing Anemia or Selectivity Data — techtimes.com, Nov 17, 2026